ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,786.20
-1.32%
S&P ASX All Technology
3,450.50
-1.11%
Brent Oil
70.165
0.65%
US Dollar vs AUD
1.5916
0.19%
Bitcoin
83,210.04
0.43%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Elevation Oncology Inc (ELEV)

  7. Elevation Oncology Inc (ELEV) News

ELEV

Elevation Oncology (ELEV)

Elevation Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELEV
DateTimeSourceHeadlineSymbolCompany
07/03/202509:12Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ELEVElevation Oncology Inc
07/03/202508:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
07/03/202508:30PR Newswire (US)Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business AchievementsNASDAQ:ELEVElevation Oncology Inc
25/02/202523:30PR Newswire (US)Elevation Oncology to Participate in Upcoming Investor ConferencesNASDAQ:ELEVElevation Oncology Inc
20/02/202508:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
20/02/202508:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
20/02/202508:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
15/02/202505:34Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELEVElevation Oncology Inc
01/02/202508:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
13/01/202523:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
13/01/202523:30PR Newswire (US)Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming MilestonesNASDAQ:ELEVElevation Oncology Inc
12/12/202423:30PR Newswire (US)Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid TumorsNASDAQ:ELEVElevation Oncology Inc
05/12/202423:30PR Newswire (US)Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024NASDAQ:ELEVElevation Oncology Inc
26/11/202423:30PR Newswire (US)Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:ELEVElevation Oncology Inc
20/11/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
15/11/202411:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELEVElevation Oncology Inc
06/11/202423:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
06/11/202423:30PR Newswire (US)Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business AchievementsNASDAQ:ELEVElevation Oncology Inc
06/11/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELEVElevation Oncology Inc
23/09/202421:30PR Newswire (US)Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2NASDAQ:ELEVElevation Oncology Inc
21/09/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
03/09/202421:30PR Newswire (US)Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ELEVElevation Oncology Inc
20/08/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
06/08/202421:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELEVElevation Oncology Inc
06/08/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
06/08/202421:10PR Newswire (US)Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business AchievementsNASDAQ:ELEVElevation Oncology Inc
06/08/202421:00PR Newswire (US)Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2NASDAQ:ELEVElevation Oncology Inc
16/07/202403:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELEVElevation Oncology Inc
27/06/202421:30PR Newswire (US)Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction CancerNASDAQ:ELEVElevation Oncology Inc
18/06/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:ELEV

Your Recent History

COIN
AVAXUSD
Avalanche
NYSE
MCD
McDonalds
COIN
ADAUSD
Cardano
ASX
XFL
S&P ASX 50
ASX
NAB
National Australia Bank
ASX
QBE
QBE Insurance
COIN
DOGEUSD
Dogecoin
FX
AUDUSD
AUD vs US Dollar
NASDAQ
AAPL
Apple
ASX
MQG
Macquarie
ASX
XJO
S&P ASX 200
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
COIN
XRPUSD
Ripple
NASDAQ
NVDA
NVIDIA
ASX
WDC
Westfield
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads